Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances in bronchiectasis.

Literature DB >> 31092516

Advances in bronchiectasis.

Abstract

Bronchiectasis is a chronic inflammatory condition with a diverse aetiology including recurrent infections, genetic abnormalities, immunodeficiency and autoimmune disorders. The prevalence has increased over the past few years and this may be due to better imaging and diagnostic techniques. Management remains the emphasis for improving symptoms and reducing exacerbations. This article focuses on highlighting the latest data released since 2014 on new diagnostic techniques as well as potential future pharmacological and non-pharmacological treatment options for patients with bronchiectasis. © Royal College of Physicians 2019. All rights reserved.

Entities: Disease Species

Keywords: Bronchiectasis; airway clearance; bronchodilators; inhaled or oral steroids; long-term antibiotics

Year: 2019 PMID： 31092516 PMCID： PMC6542217 DOI： 10.7861/clinmedicine.19-3-230

Source DB: PubMed Journal: Clin Med (Lond) ISSN： 1470-2118 Impact factor: 2.659

14 in total

1. Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.

Authors: Alan F Barker; Anne E O'Donnell; Patrick Flume; Philip J Thompson; Jonathan D Ruzi; Javier de Gracia; Wim G Boersma; Anthony De Soyza; Lixin Shao; Jenny Zhang; Laura Haas; Sandra A Lewis; Sheila Leitzinger; A Bruce Montgomery; Matthew T McKevitt; David Gossage; Alexandra L Quittner; Thomas G O'Riordan
Journal: Lancet Respir Med Date: 2014-08-18 Impact factor: 30.700

2. Bronchiectasis: An Orphan Finds a Home.

Authors: Pamela J McShane
Journal: Chest Date: 2017-05 Impact factor: 9.410

3. Treating Cough Due to Non-CF and CF Bronchiectasis With Nonpharmacological Airway Clearance: CHEST Expert Panel Report.

Authors: Adam T Hill; Alan F Barker; Donald C Bolser; Paul Davenport; Belinda Ireland; Anne B Chang; Stuart B Mazzone; Lorcan McGarvey
Journal: Chest Date: 2018-01-31 Impact factor: 9.410

Review 4. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis.

Authors: Vikas Goyal; Anne B Chang
Journal: Cochrane Database Syst Rev Date: 2014-06-10

5. British Thoracic Society Guideline for bronchiectasis in adults.

Authors: Adam T Hill; Anita L Sullivan; James D Chalmers; Anthony De Soyza; Stuart J Elborn; Andres R Floto; Lizzie Grillo; Kevin Gruffydd-Jones; Alex Harvey; Charles S Haworth; Edwin Hiscocks; John R Hurst; Christopher Johnson; Peter W Kelleher; Pallavi Bedi; Karen Payne; Hashem Saleh; Nicholas J Screaton; Maeve Smith; Michael Tunney; Deborah Whitters; Robert Wilson; Michael R Loebinger
Journal: Thorax Date: 2019-01 Impact factor: 9.139

6. Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.

Authors: Pallavi Mandal; James D Chalmers; Catriona Graham; Catherine Harley; Manjit K Sidhu; Catherine Doherty; John W Govan; Tariq Sethi; Donald J Davidson; Adriano G Rossi; Adam T Hill
Journal: Lancet Respir Med Date: 2014-03-24 Impact factor: 30.700

7. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.

Authors: Michael J Cox; Elena M Turek; Catherine Hennessy; Ghazala K Mirza; Phillip L James; Meg Coleman; Andrew Jones; Robert Wilson; Diana Bilton; William O C Cookson; Miriam F Moffatt; Michael R Loebinger
Journal: PLoS One Date: 2017-02-07 Impact factor: 3.240

8. RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

Authors: Anthony De Soyza; Timothy Aksamit; Tiemo-Joerg Bandel; Margarita Criollo; J Stuart Elborn; Elisabeth Operschall; Eva Polverino; Katrin Roth; Kevin L Winthrop; Robert Wilson
Journal: Eur Respir J Date: 2018-01-25 Impact factor: 16.671

Review 9. Macrolide antibiotics for bronchiectasis.

Authors: Carol Kelly; James D Chalmers; Iain Crossingham; Nicola Relph; Lambert M Felix; David J Evans; Stephen J Milan; Sally Spencer
Journal: Cochrane Database Syst Rev Date: 2018-03-15

10. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.

Authors: Wen Li; Zhong Qin; Jie Gao; Zhibin Jiang; Yihui Chai; Liancheng Guan; Yunzhi Chen
Journal: Chron Respir Dis Date: 2018-08-12 Impact factor: 2.444

2 in total

1. Clinical and research priorities for children and young people with bronchiectasis: an international roadmap.

Authors: Anne B Chang; Jeanette Boyd; Leanne Bell; Vikas Goyal; I Brent Masters; Zena Powell; Christine Wilson; Angela Zacharasiewicz; Efthymia Alexopoulou; Andrew Bush; James D Chalmers; Rebecca Fortescue; Adam T Hill; Bulent Karadag; Fabio Midulla; Gabrielle B McCallum; Deborah Snijders; Woo-Jung Song; Thomy Tonia; Keith Grimwood; Ahmad Kantar
Journal: ERJ Open Res Date: 2021-07-19

Review 2. Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.

Authors: Luke A Wall; Elizabeth L Wisner; Kevin S Gipson; Ricardo U Sorensen
Journal: Front Immunol Date: 2020-03-31 Impact factor: 7.561

2 in total